Our broader analyses implicated NEAT1 in influencing multiple metabolic traits (e.g. serum triglycerides, diagnosis of T2DM and coronary artery disease), that are of potential relevance to patients with NAFLD. The gene discussed is NEAT1; the disease is metabolic dysfunction-associated steatotic liver disease.